| P2093 | author name string | Greg S Martin | |
| P2860 | cites work | A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units | Q21195030 |
| | The epidemiology of sepsis in the United States from 1979 through 2000 | Q29547760 |
| | 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference | Q29618757 |
| | Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation | Q33833610 |
| | Use of clinical syndromes to target antibiotic prescribing in seriously ill children in malaria endemic area: observational study | Q33939009 |
| | Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis | Q34274614 |
| | Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths | Q34311694 |
| | Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock | Q34314380 |
| | The epidemiology of sepsis in patients with malignancy | Q34538810 |
| | Source control in the management of severe sepsis and septic shock: an evidence-based review | Q34552626 |
| | Has the mortality of septic shock changed with time | Q34756226 |
| | The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database | Q34999455 |
| | The enigma of sepsis | Q35202458 |
| | Epidemiology of sepsis in Victoria, Australia | Q36006361 |
| | Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy. | Q36147653 |
| | Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis | Q37543457 |
| | The role of infection and comorbidity: Factors that influence disparities in sepsis | Q37588175 |
| | Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis | Q37773767 |
| | Critical care and the global burden of critical illness in adults | Q37799048 |
| | Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy | Q37943123 |
| | Proof of principle: the predisposition, infection, response, organ failure sepsis staging system | Q39814132 |
| | Epidemiology of sepsis syndrome in 8 academic medical centers | Q40647998 |
| | Epidemiology of nosocomial fungal infection in the 1990s | Q44633263 |
| | International study of the prevalence and outcomes of infection in intensive care units | Q44988294 |
| | The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis | Q47765940 |
| | Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. | Q50738804 |
| | Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. | Q51639404 |
| | Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. | Q53238938 |
| | The patient-related costs of care for sepsis patients in a United Kingdom adult general intensive care unit. | Q53995671 |
| | Sepsis in European intensive care units: results of the SOAP study. | Q54471944 |
| | American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference | Q55879451 |
| | Procalcitonin: THE marker of sepsis? | Q64127172 |
| | American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis | Q68141412 |
| | Germs | Q70431267 |
| | Economic burden of illness imposed by severe sepsis in Austria | Q73039104 |
| | Seasonal variation in the epidemiology of sepsis | Q79431696 |
| | Occurrence and outcomes of sepsis: influence of race | Q79667927 |
| | Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia | Q79811367 |
| | Burden of illness imposed by severe sepsis in Switzerland | Q79980493 |
| | Epidemiology of sepsis: recent advances | Q81077788 |
| | Facing the challenge: decreasing case fatality rates in severe sepsis despite increasing hospitalizations | Q81455611 |
| | Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock | Q83177700 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sepsis | Q183134 |
| | septic shock | Q1765564 |
| P304 | page(s) | 701-6 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | Expert Review of Anti-infective Therapy | Q15734432 |
| P1476 | title | Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes | |
| P478 | volume | 10 | |